The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan

European Neurology

Volumn 65, Issue 2, 2011, Pages 99-104

  Wang, Kai Chen ^a,b,c   Tsai, Ching Piao ^c   Lee, Chao Lin ^c,d   Chen, Shao Yuan ^e   Chen, Shyi Jou ^a,f,g  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e CARDINAL TIEN HOSPITAL   (Taiwan)

^f TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^g Graduate Institute of Microbiology and Immunology   (Taiwan)

Author keywords

Aquaporin 4; Expanded Disability Status Scale; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; RELAPSE; SPINAL CORD LESION; TAIWAN;

ADULT; AQUAPORIN 4; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; PREVALENCE; RETROSPECTIVE STUDIES; SPINAL CORD; TAIWAN;

EID: 79151476396     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322740     Document Type: Article

References (45)

1. Hazin R, Khan F, Bhatti MT: Neuromyelitis optica: current concepts and prospects for future management. Curr Opin Ophthalmol 2009; 20: 434-439.
2. de Seze J, Lebrun C, Stojkovic T, Ferriby D, Chatel M, Vermersch P: Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 2003; 9: 521-525. (Pubitemid 37287734)
3. Cree B: Neuromyelitis optica: diagnosis, pathogenesis, and treatment. Curr Neurol Neurosci Rep 2008; 8: 427-433.
4. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG: The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-1114. (Pubitemid 29442132)
5. Cornelio DB, Braga RP, Rosa MW, Ayub AC: Devic's neuromyelitis optica and pregnancy: distinction from multiple sclerosis is essential. Arch Gynecol Obstet 2009; 280: 475-477.
6. Cabre P, Gonzalez-Quevedo A, Bonnan M, Saiz A, Olindo S, Graus F, Smadja D, Merle H, Thomas L, Cabrera-Gomez JA: Relapsing neuromyelitis optica: long term history and clinical predictors of death. J Neurol Neurosurg Psychiatry 2009; 80: 1162-1164.
7. Tanaka K, Tani T, Tanaka M, Saida T, Idezuka J, Yamazaki M, Tsujita M, Nakada T, Sakimura K, Nishizawa M: Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 2007; 13: 850-855. (Pubitemid 351540855)
8. Tanaka M, Tanaka K, Komori M: Interferonbeta( 1b) treatment in neuromyelitis optica. Eur Neurol 2009; 62: 167-170.
9. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489. (Pubitemid 43958540)
10. Saiz A, Zuliani L, Blanco Y, Tavolato B, Giometto B, Graus F: Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients. J Neurol 2007; 254: 1233-1237. (Pubitemid 350112363)
11. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112. (Pubitemid 39626806)
12. Lehmann GL, Gradilone SA, Marinelli RA: Aquaporin water channels in central nervous system. Curr Neurovasc Res 2004; 1: 293-303.
13. Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y: Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007; 130: 1224-1234. (Pubitemid 47355951)
14. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF: Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007; 130: 1194-1205. (Pubitemid 47355941)
15. Adoni T, Lino AM, Marchiori PE, Kok F, Callegaro D: Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica. Arq Neuropsiquiatr 2008; 66: 295-297. (Pubitemid 352030269)
16. Kanzaki M, Mochizuki H, Ogawa G, Tanaka K, Araki M, Motoyoshi K, Hammond-Tooke G, Kamakura K: Clinical features of opticospinal multiple sclerosis with anti-aquaporin 4 antibody. Eur Neurol 2008; 60: 37-42. (Pubitemid 351799066)
17. Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, Watanabe S, Takahashi T, Nishiyama S, Shiga Y, Sato S, Weinshenker BG, Itoyama Y: Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006; 77: 1073-1075. (Pubitemid 44338534)
18. Bar-Zohar D, Agosta F, Goldstaub D, Filippi M: Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives. Mult Scler 2008; 14: 719-727.
19. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, Comi G, Ader HJ, Losseff N, Valk J: Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-2069. (Pubitemid 27493740)
20. Bichuetti DB, Oliveira EM, Souza NA, Rivero RL, Gabbai AA: Neuromyelitis optica in Brazil: a study on clinical and prognostic factors. Mult Scler 2009; 15: 613-619.
21. Hung TP, Landsborough D, Hsi MS: Multiple sclerosis amongst Chinese in Taiwan. J Neurol Sci 1976; 27: 459-484.
22. Lai CH, Tseng HF: Population-based epidemiological study of neurological diseases in Taiwan. 1. Creutzfeldt-Jakob disease and multiple sclerosis. Neuroepidemiology 2009; 33: 247-253.
23. Tsai CP, Yuan CL, Yu HY, Chen C, Guo YC, Shan DE: Multiple sclerosis in Taiwan. J Chin Med Assoc 2004; 67: 500-505. (Pubitemid 40069082)
24. Poser CM, Brinar VV: Diagnostic criteria for multiple sclerosis: a historical review. Clin Neurol Neurosurg 2004; 106: 147-158. (Pubitemid 38716141)
25. Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-1452. (Pubitemid 14237132)
26. Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J: Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007; 130: 1206-1223. (Pubitemid 47355945)
27. Cabrera-Gomez JA, Bonnan M, Gonzalez- Quevedo A, Saiz-Hinarejos A, Marignier R, Olindo S, Graus F, Smadja D, Merle H, Thomas L, Gomez-Garcia A, Cabre P: Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies. Mult Scler 2009; 15: 828-833.
28. Marignier R, De Seze J, Vukusic S, Durand- Dubief F, Zephir H, Vermersch P, Cabre P, Cavillon G, Honnorat J, Confavreux C: NMO-IgG and Devic's neuromyelitis optica: a French experience. Mult Scler 2008; 14: 440-445. (Pubitemid 351943855)
29. Collongues N, Marignier R, Zephir H, Papeix C, Fontaine B, Blanc F, Rodriguez D, Fleury M, Vukusic S, Pelletier J, Audoin B, Thouvenot E, Camu W, Barroso B, Ruet A, Brochet B, Vermersch P, Confavreux C, de Seze J: Long-term follow-up of neuromyelitis optica with a pediatric onset. Neurology 2010; 75: 1084-1088.
30. Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, Franciotta D, Bergamaschi R, Littleton E, Palace J, Seelig HP, Hohlfeld R, Vincent A, Zipp F: Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med 2007; 4:e133.
31. Chan KH, Ramsden DB, Yu YL, Kwok KH, Chu AC, Ho PW, Kwan JS, Lee R, Lim E, Kung MH, Ho SL: Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese. Eur J Neurol 2009; 16: 310-316.
32. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG: Neuromyelitis optica and non-organ- specific autoimmunity. Arch Neurol 2008; 65: 78-83.
33. McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Hinson SR, Kryzer TJ, Lucchinetti CF, Weinshenker BG, Wingerchuk DM, Shuster EA, Pittock SJ: Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol 2009; 66: 1134-1138.
34. Matsushita T, Isobe N, Matsuoka T, Shi N, Kawano Y, Wu XM, Yoshiura T, Nakao Y, Ishizu T, Kira JI: Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibodynegative opticospinal multiple sclerosis in Japanese. Mult Scler 2009; 15: 834-847.
35. Sahraian MA, Moinfar Z, Khorramnia S, Mohammad Ebrahim M: Relapsing neuromyelitis optica: demographic and clinical features in Iranian patients. Eur J Neurol 2010; 17: 794-799.
36. Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ: Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch Neurol 2009; 66: 1164-1167.
37. Doi H, Matsushita T, Isobe N, Matsuoka T, Minohara M, Ochi H, Kira JI: Hypercomplementemia at relapse in patients with antiaquaporin- 4 antibody. Mult Scler 2009; 15: 304-310.
38. Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B: Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 2008; 4: 202-214. (Pubitemid 351516748)
39. Vendrame M, Azizi SA: The spectrum of neuromyelitis optica: a case of NMO with extensive brain stem involvement. Neurol Res 2007; 29: 32-35. (Pubitemid 46185067)
40. Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y: Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 2005; 65: 1479-1482. (Pubitemid 41552787)
41. Chan KH, Tsang KL, Fong GC, Cheung RT, Ho SL: Idiopathic severe recurrent transverse myelitis: a restricted variant of neuromyelitis optica. Clin Neurol Neurosurg 2005; 107: 132-135. (Pubitemid 40228974)
42. Matsushita T, Isobe N, Piao H, Matsuoka T, Ishizu T, Doi H, Masaki K, Yoshiura T, Yamasaki R, Ohyagi Y, Kira J: Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status. J Neurol Sci 2010; 291: 37-43.
43. Lalive PH, Menge T, Barman I, Cree BA, Genain CP: Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays. Neurology 2006; 67: 176-177. (Pubitemid 44305492)
44. Cohen DM, Patel CB, Ahobila-Vajjula P, Sundberg LM, Chacko T, Liu SJ, Narayana PA: Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI. NMR Biomed 2009; 22: 332-341.
45. Weinstock-Guttman B, Miller C, Yeh E, Stosic M, Umhauer M, Batra N, Munschauer F, Zivadinov R, Ramanathan M: Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica. Mult Scler 2008; 14: 1061-1067.